Response to comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC". Lock S, Baumann M. Radiother Oncol 2022;170:251.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lock S, Baumann M. Response to comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC". Radiother Oncol 2022;170:251.
PMID: 35278594